홈HTD • FRA
add
코르셉트 테라퓨틱스
전일 종가
€70.96
일일 변동폭
€70.70 - €70.70
52주 변동폭
€37.48 - €105.30
시가총액
89.34억 USD
평균 거래량
6.00
주가수익률
-
배당수익률
-
기본 거래소
NASDAQ
뉴스
정보
Corcept Therapeutics Inc. is a pharmaceutical company engaged in the discovery, development and commercialization of drugs for the treatment of severe metabolic, psychiatric and oncologic disorders. Corcept has focused on the adverse effects of excess cortisol, studying new compounds that may mitigate those effects. Its executive team is headed by CEO, president and director Joseph K. Belanoff, MD. Wikipedia
설립
1998. 5. 13.
웹사이트
직원 수
500